| Name | Title | Contact Details |
|---|
O2 Concepts has reimagined non-delivery, stepping forward as the first manufacturer to create a smart POC integrated over the Verizon Network that benefits dealers and patients alike. Dynamic Network Analysis (DNA) allows oxygen providers to monitor all devices remotely for location, usage and performance, as well as troubleshoot to prevent any unnecessary dispatches. DNA Technology™ serves as an additional upgrade to 24/7 reliability and the Oxlife Independence`s standard 5 year warranty. O2 Concepts is privately held with factory operations in Newtown, CT and all products are proudly made in the USA.
Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (“Virtual Transcriptomics”). This unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The Elucid software is available for commercial use in the U.S. and Europe
TacMed Solutions™ was formed to develop quality, effective supplies and equipment for combat and tactical medicine. We knew what worked for us in that environment and wanted to share it with as many people as possible. Our products reflect our experience, situations we have faced and friends we have lost. Our goal is to prevent others from experiencing those losses by offering equipment that allows them to operate more efficiently and effectively. Minimizing preventable death in a combat or tactical environment is a realistic and attainable goal and we are proud to offer products that will help you reach it. All of our employees are former tactical medical professionals or have a close relationship with them. We maintain close ties with some of the most elite and experienced medics in the world and every one of our products must pass their evaluation before we put our name on it. We understand the principles of human performance as it relates to combat stress and design our products to complement that performance not complicate it. This approach to product development and evaluation leads to products that truly work in combat. We don`t design products to pass a structured laboratory test in a controlled environment or barely meet a requirement as a substitute. They are designed to function when there is no structure, when you have minimal supplies and very little time. When there is no one else there to help, and you probably have more than one casualty. You are trying to save lives while someone is trying to take yours. That is the environment of the tactical health care provider and that is where our products excel.
APPLIED OPTRONICS is a South Plainfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company`s focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Approximately 1.7 million Americans have AAA, and the incidence of the condition increases with age. Endologix is currently marketing the AFX® Endovascular AAA System is available in the U.S., Europe, Latin America and other regions. The Nellix® EndoVascular Aneurysm Sealing System, a novel aneurysm sealing system, is approved for sale in Europe and other markets and for investigational use in the U.S. The Powerlink with IntuiTrak® Delivery System is available in Japan. These technologies are minimally invasive, allowing for greater patient comfort and quicker recovery compared to invasive surgical alternatives. Endologix products are protected by at least 52 U.S. patents with at least 956 allowed claims. Endologix is a publicly-held company trading on NASDAQ: ELGX. The Company`s corporate office is located in Irvine, California.